Skip to content

Vascular Function and Uterine Fibroids

Sympathetic Nerve Activity and Vascular Function in Women With Uterine Leiomyomata

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02123069
Enrollment
28
Registered
2014-04-25
Start date
2013-04-30
Completion date
2018-03-01
Last updated
2018-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leiomyoma

Keywords

Autonomic nervous system, Blood pressure, Blood vessels, Physiological effects of drugs, Vascular stiffness

Brief summary

The purpose of this study is to learn how uterine fibroids may be connected to heart disease and high blood pressure. It is not known what causes fibroids, but they frequently occur in women who also have high blood pressure, heart disease, and stroke. The investigators of this study want to learn if certain changes in the blood vessels or nerve activity can put women at risk for these diseases and for fibroids.

Detailed description

The investigators are inviting women, 25-50 years old, who have not gone through menopause to participate in this study. The investigators are looking for some women with uterine fibroids and some without uterine fibroids based on ultrasound or MRI. If the patients have not had a recent ultrasound or MRI of the uterus, a physician can provide one. Individuals cannot participate if they have high blood pressure, diabetes, or disease in the kidneys, lungs, or blood vessels. Also, individuals who smoke, have high cholesterol, or are obese (BMI is higher than 30) cannot participate. Certain medications, including high blood pressure medications, beta-blockers and anti-depressants, will also limit potential patient participation. The investigators would be happy to review medications for potential participants. Screen Day: One of the members of the research team will review the study and the informed consent document with the patient. The patient will have their height, weight, blood pressure, pulse and respirations measured. The patient will also complete three questionnaires. If the patient has not had an ultrasound of the uterus in the last 12 months, a physician will complete one for her. Study Day: The patient will need to fast overnight (no eating or drinking). The investigators will draw a blood sample and then do a series of tests on the participant's blood vessels. For some of the tests, medication will be given through an IV. The investigators will also test nerve activity in the nerve on the outer aspect of the leg.

Interventions

DEVICEBrachial artery catheter

A catheter will be placed in the brachial artery by a physician on the study day.

DRUGAcetylcholine

Acetylcholine will be infused into the brachial catheter while blood flow levels in the forearm are measured. Acetylcholine will be infused at the following doses: 1.0, 2.0, 4.0, and 8.0 ug/100 ml tissue/min for 2 minutes each.

Nitroprusside will be infused into the brachial catheter while blood flow levels in the forearm are measured. Nitroprusside will be infused at the following doses: 0.25, 0.5, 1.0, and 2.0 ug/100 ml tissue/min for 2 minutes each.

DRUGNorepinephrine

Norepinephrine will be infused into the brachial catheter while blood flow levels in the forearm are measured. Norepinephrine will be infused at the following doses: 1.0, 2.0, 4.0, and 8.0 ug/100 ml tissue/min for 2 minutes each.

DRUGNitroprusside and phenylephrine

A single dose of nitroprusside (100 ug) will be infused through an IV; one minute later, a single dose of phenylephrine (150 ug) will be infused.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Women 25-50 years old * Premenopausal

Exclusion criteria

* Postmenopausal * Pregnant or currently breastfeeding * Using blood pressure medications or anti-depression medications * High blood pressure * Diabetes * Disease in the kidneys, lungs, or blood vessels * Chronic diseases (for example: Crohn's disease, rheumatoid arthritis, bipolar mood disorder, etc.) * Smoker * High cholesterol * BMI higher than 30

Design outcomes

Primary

MeasureTime frameDescription
Baseline sympathetic nerve activityOne day (study day)Nerve burst activity will be measured across 10 minutes.
Baseline systolic, diastolic, and mean blood pressuresOne day (study day)

Secondary

MeasureTime frameDescription
Changes in forearm blood flow levels in response to nitroprusside infusionOne day (study day)
Changes in forearm blood flow levels in response to norepinephrine infusionOne day (study day)
Pulse wave velocity (an index of vessel stiffness)One day (study day)
Change in blood pressure in response to infusions of nitroprusside and phenylephrineOne day (study)An infusion of nitroprusside will be given, followed by an infusion of phenylephrine one minute later.
Changes in forearm blood flow levels in response to acetylcholine infusionOne day (study day)

Other

MeasureTime frameDescription
Female sex hormone levelsOne day (study day)Blood samples will be collected to measure levels of estrogen and progesterone.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026